KR890005277A - 2본쇄 rna 부족 상태의 진단 및 치료방법 - Google Patents

2본쇄 rna 부족 상태의 진단 및 치료방법 Download PDF

Info

Publication number
KR890005277A
KR890005277A KR1019880011423A KR880011423A KR890005277A KR 890005277 A KR890005277 A KR 890005277A KR 1019880011423 A KR1019880011423 A KR 1019880011423A KR 880011423 A KR880011423 A KR 880011423A KR 890005277 A KR890005277 A KR 890005277A
Authority
KR
South Korea
Prior art keywords
dsrna
mismatched
amount
administered
deficiency
Prior art date
Application number
KR1019880011423A
Other languages
English (en)
Korean (ko)
Inventor
에이.카터 윌리엄
Original Assignee
원본미기재
헴 리서치 인코오포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 헴 리서치 인코오포레이티드 filed Critical 원본미기재
Publication of KR890005277A publication Critical patent/KR890005277A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
KR1019880011423A 1987-09-04 1988-09-03 2본쇄 rna 부족 상태의 진단 및 치료방법 KR890005277A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9352387A 1987-09-04 1987-09-04
US093,523 1987-09-04

Publications (1)

Publication Number Publication Date
KR890005277A true KR890005277A (ko) 1989-05-13

Family

ID=22239406

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880011423A KR890005277A (ko) 1987-09-04 1988-09-03 2본쇄 rna 부족 상태의 진단 및 치료방법

Country Status (15)

Country Link
JP (1) JPH0825884B2 (zh)
KR (1) KR890005277A (zh)
CN (1) CN1031651A (zh)
AU (3) AU2186488A (zh)
CA (1) CA1336683C (zh)
DK (1) DK491088A (zh)
FI (1) FI884069A (zh)
IL (1) IL87664A (zh)
NO (1) NO883868L (zh)
NZ (1) NZ226033A (zh)
OA (1) OA08911A (zh)
PH (1) PH26320A (zh)
PT (1) PT88415B (zh)
RU (1) RU2001917C1 (zh)
ZA (1) ZA886581B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088344C (zh) * 1997-10-17 2002-07-31 青岛市卫生防疫站 富硒或富锌蚯蚓干粉或提取物的制造方法
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
JPS57200310A (en) * 1981-05-26 1982-12-08 Merck & Co Inc Local application of interferon inducer
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
OA08911A (en) 1989-10-31
PT88415B (pt) 1992-10-30
JPH0825884B2 (ja) 1996-03-13
CA1336683C (en) 1995-08-15
DK491088D0 (da) 1988-09-02
IL87664A (en) 1995-03-15
FI884069A (fi) 1989-03-05
DK491088A (da) 1989-03-05
RU2001917C1 (ru) 1993-10-30
AU1001495A (en) 1995-03-30
AU1736692A (en) 1992-07-30
IL87664A0 (en) 1989-02-28
JPH01131118A (ja) 1989-05-24
FI884069A0 (fi) 1988-09-02
NO883868L (no) 1989-03-06
NO883868D0 (no) 1988-08-30
PH26320A (en) 1992-04-29
NZ226033A (en) 1999-08-30
PT88415A (pt) 1989-07-31
ZA886581B (en) 1989-04-26
AU2186488A (en) 1989-03-09
CN1031651A (zh) 1989-03-15

Similar Documents

Publication Publication Date Title
Rudge et al. Encephalomyelitis in primary hypogammaglobulinaemia
Ogbuokiri et al. Ivermectin levels in human breastmilk
Rutkove An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a
Glass et al. Oral treatment of pernicious anemia with small doses of vitamin B12 combined with mucinous materials derived from the hog stomach
KR890005277A (ko) 2본쇄 rna 부족 상태의 진단 및 치료방법
KR20100024019A (ko) 다목적 식품첨가용 미네랄 농축액 및 이의 제조방법
Wong et al. An association between serum-magnesium and tremor and convulsions in infants and children
Shoenfeld et al. Carbamazepine (Tegretol)-induced thrombocytopenia
David et al. Typhoid fever: unusual presentation
Brodsky et al. Effect of testosterone enanthate and alkylating agents on multiple myeloma
WO2004064767A2 (en) Nitric oxide inducing agents
KR101130617B1 (ko) 다기능성 미네랄 복합체를 함유하는 기능성 음료
RU2196576C1 (ru) Способ лечения больных геморрагической лихорадкой с почечным синдромом (глпс)
SU1170348A1 (ru) Способ определени индивидуальной чувствительности организма на введение коклюшной вакцины
RU2058772C1 (ru) Способ бальнеотерапии ванной больных сахарным диабетом
Heffelfinger et al. Neurotoxicity with nitrofurantoin: A case report
Skårberg et al. Oxymetholone Treatment in Hypoproliferative Anaemia1: I. Frequency of Response
RH et al. Blood grouping on blotting-paper.
Naveen et al. COMPARATIVE RESEARCH STUDY ON BIOCHEMICAL ANALYSIS OF UNPURIFIED AND PURIFIED MIRUTHAR SINGI (LEAD SULPHIDE)
Cope Endocrinology And Nutrition
RU1780752C (ru) Способ иммунотерапии
Solomons et al. L-arginine, the sickling phenomenon, and cystic fibrosis
Ordway Remissions in leukæmia produced by radium in cases completely resistant to X-ray and benzol treatment
Gambill et al. Effect of intravenous administration of nicotinic acid on blood bilirubin
Levkovitz et al. Leukocytosis related to the therapeutic dosage of sulpiride

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application